Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

Journal of the American College of Cardiology

Volumn 60, Issue 8, 2012, Pages 749-755

  Buber, Jonathan ^a,d   Goldenberg, Ilan ^a,b   Moss, Arthur J ^b   Wang, Paul J ^c   McNitt, Scott ^b   Hall, W Jackson ^b   Eldar, Michael ^a   Barsheshet, Alon ^b   Shechter, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

heart failure; statins; ventricular arrhythmias

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CIGARETTE SMOKING; CONTROLLED STUDY; DEFIBRILLATION; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART BEAT; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); MULTIVARIATE ANALYSIS; NONISCHEMIC CARDIOMYOPATHY; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RISK REDUCTION; TREATMENT OUTCOME;

ADULT; AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STATISTICS, NONPARAMETRIC; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84865127976     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.03.041     Document Type: Article

References (20)

1. H.V. Huikuri, G.A. Castellanos, R.J. Myerburg Sudden death due to cardiac arrhythmias N Engl J Med 345 2001 1473 1482
2. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
3. LIPID Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
4. A.K. Vyas, H. Guo, A.J. Moss MADIT-II Research Group Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II J Am Coll Cardiol 47 2006 769 773 (Pubitemid 43243099)
5. G. Levantesi, M. Scarano, R. Marfisi Meta-analysis of effect of statin treatment on risk of sudden death Am J Cardiol 100 2007 1644 1650 (Pubitemid 350122329)
6. B. Vrtovec, R. Okrajsek, A. Golicnik Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure J Card Fail 14 2008 140 144 (Pubitemid 351312881)
7. J. De Sutter, R. Tavernier, M. De Buyzere, L. Jordaens, G. De Backer Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients J Am Coll Cardiol 36 2000 766 772
8. L.B. Mitchell, J.L. Powell, A.M. Gillis, V. Kehl, A.P. Hallstrom AVID Investigators Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial J Am Coll Cardiol 42 2003 81 87 (Pubitemid 36760765)
9. J.J. Goldberger, H. Subacius, A. Schaechter DEFINITE Investigators Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy J Am Coll Cardiol 48 2006 1228 1233 (Pubitemid 44363151)
10. A.J. Moss, W.J. Hall, D.S. Cannom MADIT-CRT Trial Investigators Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
11. H. Greenberg, R.B. Case, A.J. Moss Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II) J Am Coll Cardiol 43 2004 1459 1465 (Pubitemid 38496355)
12. E.M. Pound, J.X. Kang, A. Leaf Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes J Lipid Res 42 2001 346 351 (Pubitemid 32270057)
13. A.N. Pehlivanidis, V.G. Athyros, D.S. Demitriadis Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease Atherosclerosis 157 2001 463 469 (Pubitemid 32710027)
14. B. Vrtovec, R. Okrajsek, A. Golicnik Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure J Card Fail 11 2005 684 690 (Pubitemid 41797497)
15. -/- mice in vivo Circulation 107 2003 2480 2486 (Pubitemid 36605232)
16. I. Goldenberg, A.J. Moss, S. McNitt MADIT-II Investigators Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators J Cardiovasc Electrophysiol 17 2006 931 936
17. J. Kjekshus, E. Apetrei, V. Barrios CORONA Investigators Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261 (Pubitemid 350190755)
18. L. Tavazzi, G. Tognoni, A.P. Maggioni GISSI HF Investigators Effect of rosuvastatin in patients with chronic heart failure: a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1231 1239
19. L. Mark, A. Katona Effect of fluvastatin on QT dispersion: a new pleiotropic effect? Am J Cardiol 85 2000 919 920 (Pubitemid 30160032)
20. A. Barsheshet, P.J. Wang, A.J. Moss MADIT CRT Investigators Reverse remodeling and the risk of ventricular tachyarrhythmias in MADIT-CRT J Am Coll Cardiol 57 2011 2416 2423